| Bianca Bonniwell, OTR/L | |
|
300 Catlin St, Buffalo, MN 55313-2012 | |
| (763) 684-3888 | |
| Not Available |
| Full Name | Bianca Bonniwell |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 12 Years |
| Location | 300 Catlin St, Buffalo, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639597685 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | (Minnesota) | Secondary |
| 225X00000X | Occupational Therapist | 104457 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Croix Regional Medical Center | 9335032184 | 164 |
| St. Croix Regional Medical Center | 9335032184 | 164 |
News Archive
There is a new technology available that can help with both predicting prostate cancer aggressiveness and detecting prostate cancer. It's called fusion guided biopsy, and Valley–Mount Sinai Comprehensive Cancer Care is proud to offer the UroNav Fusion Biopsy System to its patients as an outpatient procedure.
Direct-to-consumer advertising for commercial genetic testing is on the rise and may be problematic, according to a Massachusetts General Hospital (MGH) physician. In the December issue of Obstetrics & Gynecology, Erin Tracy, MD, MPH, warns that such testing is poorly regulated and may present potential pitfalls for patients and physicians.
The international drug procurement agency UNITAID on Monday unveiled plans to create a patent pool for HIV/AIDS medications to help increase access to generic versions of newer drugs at lower prices for low- and middle-income countries, Agence France-Presse reports. The patent pool "will create a common space for patent holders to license their technology in exchange for royalties" and is "scheduled to begin operating in mid-2010," AFP reports (12/14).
Eisai Inc. today announced that LUSEDRA(TM) (fospropofol disodium) Injection is now available for use by persons trained in the administration of general anesthesia. LUSEDRA, an aqueous solution, is an intravenous sedative-hypnotic agent indicated for monitored anesthesia care (MAC) sedation in adult patients undergoing diagnostic or therapeutic procedures.
Shield Therapeutics (Shield), the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals which address areas of high unmet medical need, today announced that the first patients have been treated in the two Phase 3 clinical studies of ST10 for the treatment of iron deficiency anaemia (IDA) in subjects with inflammatory bowel disease.
› Verified 6 days ago
| Provider Name | St. Croix Regional Medical Center |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1043240922 PECOS PAC ID: 9335032184 Enrollment ID: O20110929000165 |
News Archive
There is a new technology available that can help with both predicting prostate cancer aggressiveness and detecting prostate cancer. It's called fusion guided biopsy, and Valley–Mount Sinai Comprehensive Cancer Care is proud to offer the UroNav Fusion Biopsy System to its patients as an outpatient procedure.
Direct-to-consumer advertising for commercial genetic testing is on the rise and may be problematic, according to a Massachusetts General Hospital (MGH) physician. In the December issue of Obstetrics & Gynecology, Erin Tracy, MD, MPH, warns that such testing is poorly regulated and may present potential pitfalls for patients and physicians.
The international drug procurement agency UNITAID on Monday unveiled plans to create a patent pool for HIV/AIDS medications to help increase access to generic versions of newer drugs at lower prices for low- and middle-income countries, Agence France-Presse reports. The patent pool "will create a common space for patent holders to license their technology in exchange for royalties" and is "scheduled to begin operating in mid-2010," AFP reports (12/14).
Eisai Inc. today announced that LUSEDRA(TM) (fospropofol disodium) Injection is now available for use by persons trained in the administration of general anesthesia. LUSEDRA, an aqueous solution, is an intravenous sedative-hypnotic agent indicated for monitored anesthesia care (MAC) sedation in adult patients undergoing diagnostic or therapeutic procedures.
Shield Therapeutics (Shield), the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals which address areas of high unmet medical need, today announced that the first patients have been treated in the two Phase 3 clinical studies of ST10 for the treatment of iron deficiency anaemia (IDA) in subjects with inflammatory bowel disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bianca Bonniwell, OTR/L 18270 715th Ave, Dassel, MN 55325-7546 Ph: (320) 221-1579 | Bianca Bonniwell, OTR/L 300 Catlin St, Buffalo, MN 55313-2012 Ph: (763) 684-3888 |
News Archive
There is a new technology available that can help with both predicting prostate cancer aggressiveness and detecting prostate cancer. It's called fusion guided biopsy, and Valley–Mount Sinai Comprehensive Cancer Care is proud to offer the UroNav Fusion Biopsy System to its patients as an outpatient procedure.
Direct-to-consumer advertising for commercial genetic testing is on the rise and may be problematic, according to a Massachusetts General Hospital (MGH) physician. In the December issue of Obstetrics & Gynecology, Erin Tracy, MD, MPH, warns that such testing is poorly regulated and may present potential pitfalls for patients and physicians.
The international drug procurement agency UNITAID on Monday unveiled plans to create a patent pool for HIV/AIDS medications to help increase access to generic versions of newer drugs at lower prices for low- and middle-income countries, Agence France-Presse reports. The patent pool "will create a common space for patent holders to license their technology in exchange for royalties" and is "scheduled to begin operating in mid-2010," AFP reports (12/14).
Eisai Inc. today announced that LUSEDRA(TM) (fospropofol disodium) Injection is now available for use by persons trained in the administration of general anesthesia. LUSEDRA, an aqueous solution, is an intravenous sedative-hypnotic agent indicated for monitored anesthesia care (MAC) sedation in adult patients undergoing diagnostic or therapeutic procedures.
Shield Therapeutics (Shield), the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals which address areas of high unmet medical need, today announced that the first patients have been treated in the two Phase 3 clinical studies of ST10 for the treatment of iron deficiency anaemia (IDA) in subjects with inflammatory bowel disease.
› Verified 6 days ago
Bethany Crystal Skinner, MAOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1801 Highway 25 N, Buffalo, MN 55313 Phone: 763-682-4336 | |
Glenna M Kramer, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 303 Catlin St, Buffalo, MN 55313 Phone: 763-684-3856 | |
Alyssa K Farrell, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Catlin St Ste 101, Buffalo, MN 55313 Phone: 763-684-3889 | |
Joanne Irene Sypnieski, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 300 Catlin St Ste 101, Buffalo, MN 55313 Phone: 763-684-7024 Fax: 763-684-3884 | |
Strive Therapy Services Inc. Occupational Therapist Medicare: Medicare Enrolled Practice Location: 12 1st Ave S, Buffalo, MN 55313 Phone: 763-682-7774 Fax: 763-682-2312 | |
Shannon Pfeifer, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 25 1st Ave Ne, Suite 200, Buffalo, MN 55313 Phone: 763-682-0665 | |
Jaime Ellen Plamann, MOTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 12 1st Ave S, Buffalo, MN 55313 Phone: 763-682-7774 |